REPORT ID 3566

Global Hemophilia A Drug Market Research Report 2017

Publish Date
14-Dec-17
Pages
117
Format
Electronic (PDF)

In this report, the global Hemophilia A Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hemophilia A Drug in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Hemophilia A Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Bayer AG
    BioMarin Pharmaceutical Inc
    Bioverativ Inc
    Catalyst Biosciences Inc
    Chugai Pharmaceutical Co Ltd
    CSL Ltd
    DBV Technologies SA
    Dimension Therapeutics Inc
    EpiVax Inc
    Expression Therapeutics LLC
    Green Cross Corp
    Idogen AB
    Immusoft Corp
    LFB SA
    mAbxience SA
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    ATXF-8117
    BAY-1093884
    BIVV-001
    BS-027125
    Concizumab
    CSL-689
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Clinic
    Hospital
    ASCs

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Hemophilia A Drug Market Research Report 2017
1 Hemophilia A Drug Market Overview
    1.1 Product Overview and Scope of Hemophilia A Drug
    1.2 Hemophilia A Drug Segment by Type (Product Category)
        1.2.1 Global Hemophilia A Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Hemophilia A Drug Production Market Share by Type (Product Category) in 2016
        1.2.3 ATXF-8117
        1.2.4 BAY-1093884
        1.2.5 BIVV-001
        1.2.6 BS-027125
        1.2.7 Concizumab
        1.2.8 CSL-689
        1.2.9 Others
    1.3 Global Hemophilia A Drug Segment by Application
        1.3.1 Hemophilia A Drug Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 ASCs
    1.4 Global Hemophilia A Drug Market by Region (2012-2022)
        1.4.1 Global Hemophilia A Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Hemophilia A Drug (2012-2022)
        1.5.1 Global Hemophilia A Drug Revenue Status and Outlook (2012-2022)
        1.5.2 Global Hemophilia A Drug Capacity, Production Status and Outlook (2012-2022)

2 Global Hemophilia A Drug Market Competition by Manufacturers
    2.1 Global Hemophilia A Drug Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Hemophilia A Drug Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Hemophilia A Drug Production and Share by Manufacturers (2012-2017)
    2.2 Global Hemophilia A Drug Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Hemophilia A Drug Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Hemophilia A Drug Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Hemophilia A Drug Market Competitive Situation and Trends
        2.5.1 Hemophilia A Drug Market Concentration Rate
        2.5.2 Hemophilia A Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Hemophilia A Drug Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Hemophilia A Drug Capacity and Market Share by Region (2012-2017)
    3.2 Global Hemophilia A Drug Production and Market Share by Region (2012-2017)
    3.3 Global Hemophilia A Drug Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Hemophilia A Drug Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Hemophilia A Drug Consumption by Region (2012-2017)
    4.2 North America Hemophilia A Drug Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Hemophilia A Drug Production, Consumption, Export, Import (2012-2017)
    4.4 China Hemophilia A Drug Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Hemophilia A Drug Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Hemophilia A Drug Production, Consumption, Export, Import (2012-2017)
    4.7 India Hemophilia A Drug Production, Consumption, Export, Import (2012-2017)

5 Global Hemophilia A Drug Production, Revenue (Value), Price Trend by Type
    5.1 Global Hemophilia A Drug Production and Market Share by Type (2012-2017)
    5.2 Global Hemophilia A Drug Revenue and Market Share by Type (2012-2017)
    5.3 Global Hemophilia A Drug Price by Type (2012-2017)
    5.4 Global Hemophilia A Drug Production Growth by Type (2012-2017)

6 Global Hemophilia A Drug Market Analysis by Application
    6.1 Global Hemophilia A Drug Consumption and Market Share by Application (2012-2017)
    6.2 Global Hemophilia A Drug Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Hemophilia A Drug Manufacturers Profiles/Analysis
    7.1 Bayer AG
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Hemophilia A Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Bayer AG Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 BioMarin Pharmaceutical Inc
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Hemophilia A Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Bioverativ Inc
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Hemophilia A Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Bioverativ Inc Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Catalyst Biosciences Inc
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Hemophilia A Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Catalyst Biosciences Inc Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Chugai Pharmaceutical Co Ltd
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Hemophilia A Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 CSL Ltd
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Hemophilia A Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 CSL Ltd Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 DBV Technologies SA
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Hemophilia A Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 DBV Technologies SA Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Dimension Therapeutics Inc
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Hemophilia A Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Dimension Therapeutics Inc Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 EpiVax Inc
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Hemophilia A Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 EpiVax Inc Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Expression Therapeutics LLC
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Hemophilia A Drug Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Expression Therapeutics LLC Hemophilia A Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Green Cross Corp
    7.12 Idogen AB
    7.13 Immusoft Corp
    7.14 LFB SA
    7.15 mAbxience SA

8 Hemophilia A Drug Manufacturing Cost Analysis
    8.1 Hemophilia A Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Hemophilia A Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Hemophilia A Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Hemophilia A Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Hemophilia A Drug Market Forecast (2017-2022)
    12.1 Global Hemophilia A Drug Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Hemophilia A Drug Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Hemophilia A Drug Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Hemophilia A Drug Price and Trend Forecast (2017-2022)
    12.2 Global Hemophilia A Drug Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Hemophilia A Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Hemophilia A Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Hemophilia A Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Hemophilia A Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Hemophilia A Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Hemophilia A Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Hemophilia A Drug Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Hemophilia A Drug Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer